Investors are always looking for stocks that are poised to beat at earnings season and Calliditas Therapeutics AB (publ) CALT may be one such company. The firm has earnings coming up pretty soon, and ...
Caltagirone SpA (BIT:CALT) is a small-cap stock with a market capitalization of €320.72M. While investors primarily focus on the growth potential and competitive landscape of the small-cap companies, ...
Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...
Part B portion of Phase 3 NefIgArd trial reveals positive outcomes for nefecon, leading to a reaffirmed buy recommendation for Calliditas. Nefecon demonstrates statistically significant stabilization ...
Calliditas Therapeutics (NASDAQ:CALT) added 35% on Monday after announcing that its Phase 3 trial for renal disease candidate Nefecon reached the primary endpoint, paving the way for Swedish pharma to ...
PARIS — Gallic production and sales company Calt is centralizing its activities with the creation of Calt Distribution. The new division, to be headed by Sandrine Frantz, will combine the functions of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results